23RD January 2013
DAILY CHARTIST VIEW
HIGHLIGHTS A
Highlights
Nifty traded volatile and ended in negative on Tuesday Nifty Future ended 34.90 points up at 6061.55 Adani Enterprises future buy call executed and hits 1st tg 278.50 and PFC Future buy call remained unexecuted. Investors’ are advised to book profit in Adani Ent future and take position in fresh calls provided below. Buy Sun Pharma futures above 717 for targets 722/730 with sl 709 Buy NTPC future above 165 for targets 166.50/169 with sl 162.45
Past Performance: Adani Ent future executed and hits 1st tg 278.50. PFC future buy call remained unexecuted. Maruti future executed and hits 1st tg 1574. DLF future sell call hits almost 1st tg 255, low 255.15. Aanjaneya Lifecare executed and made high 850 Bharti Airtel future buy call remained unexecuted. BHEL future executed and made high 328.35 . Havells sell call hit both targets.
SUN PHARMA FUTURES – FLAG PATTERN BUY ABOVE 717 FOR TARGETS 722/730 SL 709
BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235
Buy Sun Pharma futures above 717 Sun Pharma future is making a flag pattern on 30 minute chart. Currently trading at 712.05 Investor’s are advised to buy above 717, break out is yet to come. Targets are 722/730 and SL is recommended at 709. This is an intraday call as the pattern is forming on 30 minutes chart.
NTPC FUTURE – SYMMETRICAL TRIANGLE BUY ABOVE 165 FOR TARGETS 166.50/169 SL 162.45
Buy NTPC future above 165 NTPC future is making a symmetrical triangle pattern on 15 minutes chart. Currently trading at 163.85 Investors’ are advised to buy above 165 for targets 166.50/169, Breakout is yet to come. Targets are 166.50/169 and SL recommended is 162.45
Disclaimer The information and view in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any other information provided by us to/with anyone which is related directly or indirectly with them. If found so, then Serious Legal Actions can be taken.